253 related articles for article (PubMed ID: 17890243)
21. Hypermethylation in human cancers of the RIZ1 tumor suppressor gene, a member of a histone/protein methyltransferase superfamily.
Du Y; Carling T; Fang W; Piao Z; Sheu JC; Huang S
Cancer Res; 2001 Nov; 61(22):8094-9. PubMed ID: 11719434
[TBL] [Abstract][Full Text] [Related]
22. Hypermethylation of CpG island loci of multiple tumor suppressor genes in retinoblastoma.
Cohen Y; Merhavi-Shoham E; Avraham RB; Frenkel S; Pe'er J; Goldenberg-Cohen N
Exp Eye Res; 2008 Feb; 86(2):201-6. PubMed ID: 18068703
[TBL] [Abstract][Full Text] [Related]
23. Dominant-negative histone H3 lysine 27 mutant derepresses silenced tumor suppressor genes and reverses the drug-resistant phenotype in cancer cells.
Abbosh PH; Montgomery JS; Starkey JA; Novotny M; Zuhowski EG; Egorin MJ; Moseman AP; Golas A; Brannon KM; Balch C; Huang TH; Nephew KP
Cancer Res; 2006 Jun; 66(11):5582-91. PubMed ID: 16740693
[TBL] [Abstract][Full Text] [Related]
24. Epigenome scans and cancer genome sequencing converge on WNK2, a kinase-independent suppressor of cell growth.
Hong C; Moorefield KS; Jun P; Aldape KD; Kharbanda S; Phillips HS; Costello JF
Proc Natl Acad Sci U S A; 2007 Jun; 104(26):10974-9. PubMed ID: 17578925
[TBL] [Abstract][Full Text] [Related]
25. [The roles of DNA methylation in human neoplasms].
Yuan YF; Li JQ; Yang ZL; Wang JP
Ai Zheng; 2002 Nov; 21(11):1267-77. PubMed ID: 12526230
[TBL] [Abstract][Full Text] [Related]
26. Homo sapiens lactate dehydrogenase c (Ldhc) gene expression in cancer cells is regulated by transcription factor Sp1, CREB, and CpG island methylation.
Tang H; Goldberg E
J Androl; 2009; 30(2):157-67. PubMed ID: 18930904
[TBL] [Abstract][Full Text] [Related]
27. The CpG island methylator phenotype correlates with long-range epigenetic silencing in colorectal cancer.
Karpinski P; Ramsey D; Grzebieniak Z; Sasiadek MM; Blin N
Mol Cancer Res; 2008 Apr; 6(4):585-91. PubMed ID: 18403637
[TBL] [Abstract][Full Text] [Related]
28. MethHC: a database of DNA methylation and gene expression in human cancer.
Huang WY; Hsu SD; Huang HY; Sun YM; Chou CH; Weng SL; Huang HD
Nucleic Acids Res; 2015 Jan; 43(Database issue):D856-61. PubMed ID: 25398901
[TBL] [Abstract][Full Text] [Related]
29. ITTACA: a new database for integrated tumor transcriptome array and clinical data analysis.
Elfilali A; Lair S; Verbeke C; La Rosa P; Radvanyi F; Barillot E
Nucleic Acids Res; 2006 Jan; 34(Database issue):D613-6. PubMed ID: 16381943
[TBL] [Abstract][Full Text] [Related]
30. Predicting methylation status of CpG islands in the human brain.
Fang F; Fan S; Zhang X; Zhang MQ
Bioinformatics; 2006 Sep; 22(18):2204-9. PubMed ID: 16837523
[TBL] [Abstract][Full Text] [Related]
31. DNA methylation changes in cancer.
Toyota M; Yamamoto E
Prog Mol Biol Transl Sci; 2011; 101():447-57. PubMed ID: 21507361
[TBL] [Abstract][Full Text] [Related]
32. Epigenetic inactivation of the candidate 3p21.3 suppressor gene BLU in human cancers.
Agathanggelou A; Dallol A; Zöchbauer-Müller S; Morrissey C; Honorio S; Hesson L; Martinsson T; Fong KM; Kuo MJ; Yuen PW; Maher ER; Minna JD; Latif F
Oncogene; 2003 Mar; 22(10):1580-8. PubMed ID: 12629521
[TBL] [Abstract][Full Text] [Related]
33. Abnormal CpG island methylation occurs during in vitro differentiation of human embryonic stem cells.
Shen Y; Chow J; Wang Z; Fan G
Hum Mol Genet; 2006 Sep; 15(17):2623-35. PubMed ID: 16870691
[TBL] [Abstract][Full Text] [Related]
34. Experimental manipulation of genomic methylation.
Jackson-Grusby L; Jaenisch R
Semin Cancer Biol; 1996 Oct; 7(5):261-8. PubMed ID: 9110403
[TBL] [Abstract][Full Text] [Related]
35. Loss of epigenetic control of synuclein-gamma gene as a molecular indicator of metastasis in a wide range of human cancers.
Liu H; Liu W; Wu Y; Zhou Y; Xue R; Luo C; Wang L; Zhao W; Jiang JD; Liu J
Cancer Res; 2005 Sep; 65(17):7635-43. PubMed ID: 16140929
[TBL] [Abstract][Full Text] [Related]
36. Molecular diagnostic applications of DNA methylation technology.
Cottrell SE
Clin Biochem; 2004 Jul; 37(7):595-604. PubMed ID: 15234241
[TBL] [Abstract][Full Text] [Related]
37. Epigenetic changes in solid and hematopoietic tumors.
Toyota M; Issa JP
Semin Oncol; 2005 Oct; 32(5):521-30. PubMed ID: 16210093
[TBL] [Abstract][Full Text] [Related]
38. The essential role of histone H3 Lys9 di-methylation and MeCP2 binding in MGMT silencing with poor DNA methylation of the promoter CpG island.
Zhao W; Soejima H; Higashimoto K; Nakagawachi T; Urano T; Kudo S; Matsukura S; Matsuo S; Joh K; Mukai T
J Biochem; 2005 Mar; 137(3):431-40. PubMed ID: 15809347
[TBL] [Abstract][Full Text] [Related]
39. The fundamental role of epigenetics in hematopoietic malignancies.
Galm O; Herman JG; Baylin SB
Blood Rev; 2006 Jan; 20(1):1-13. PubMed ID: 16426940
[TBL] [Abstract][Full Text] [Related]
40. DNA methylation and hepatocellular carcinoma.
Zhu J
J Hepatobiliary Pancreat Surg; 2006; 13(4):265-73. PubMed ID: 16858536
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
